Changing the Conversation: Immunotherapy and Long-Term SurvivalVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.
Dixie-Lee Esseltine, MD and George Mulligan, PhD explain ixazomib’s mechanism of action and how the drug may fit into the treatment regimen for patients upon approval and beyond.
Ken Schaecher, MD, presents his own personal opinion on the multiple barriers to affordable high quality care for cancer patients. Supported through funding from Incyte